Autoimmune conundrum in children with type 1 diabetes mellitus: a case series of uncommon associations

Authors

  • Simran Syal Department of Paediatrics, All India Institute of Medical Sciences (AIIMS), Raipur, Chhattisgarh, India
  • Anil Kumar Goel Department of Paediatrics, All India Institute of Medical Sciences (AIIMS), Raipur, Chhattisgarh, India
  • Sunil Jondhale Department of Paediatrics, All India Institute of Medical Sciences (AIIMS), Raipur, Chhattisgarh, India
  • Tushar B. Jagzape Department of Paediatrics, All India Institute of Medical Sciences (AIIMS), Raipur, Chhattisgarh, India
  • Akhila Gujarathi Department of Paediatrics, All India Institute of Medical Sciences (AIIMS), Raipur, Chhattisgarh, India
  • Ayushie Jain Department of Paediatrics, All India Institute of Medical Sciences (AIIMS), Raipur, Chhattisgarh, India
  • Charandeep Singh Gandhoke Department of Neurosurgery, All India Institute of Medical Sciences (AIIMS), Raipur, Chhattisgarh, India

DOI:

https://doi.org/10.18203/2349-3291.ijcp20261141

Keywords:

Diabetes mellitus type 1, Autoimmune polyendocrine syndromes, Hepatitis, Autoimmune, Purpura, Thrombocytopenic, Idiopathic, Hypoparathyroidism, Autoimmune diseases

Abstract

Type 1 diabetes mellitus (T1DM) is an autoimmune disorder commonly associated with other autoimmune conditions, particularly autoimmune thyroid disease and celiac disease. However, involvement of non-classical organs such as the liver, hematologic system and parathyroid glands is uncommon in children and often under-recognized. We report three pediatric cases illustrating diverse autoimmune associations with T1DM. The first case is a 9-year-old boy with T1DM who after four months of T1DM diagnosis, developed recurrent jaundice, ascites and splenomegaly and was diagnosed with biopsy-proven autoimmune hepatitis. The second case is a 7-year-old girl with chronic immune thrombocytopenic purpura (ITP) from early childhood who subsequently developed T1DM 4 years later. The third case is an 8-year-old girl with T1DM who presented after two years with hypocalcemic tetany due to autoimmune hypoparathyroidism and recurrent mucocutaneous candidiasis, suggestive of an autoimmune polyglandular syndrome type 1–like phenotype. These cases highlight the expanding spectrum of autoimmune disorders associated with pediatric T1DM beyond classical endocrine conditions. Restricting evaluation to routine screening alone may result in delayed diagnosis and increased morbidity. Clinicians should maintain a high index of suspicion for atypical autoimmune manifestations in children with T1DM to enable early diagnosis, appropriate management and improved long-term outcomes.

References

Triolo TM, Armstrong TK, McFann K, Yu L, Rewers MJ, Klingensmith GJ, et al. Additional autoimmune disease found in 33% of patients at type 1 diabetes onset. Diabetes Care. 2011;34(5):1211-3.

Ziegler AG, Rewers M, Simell O, Simell T, Lempainen J, Steck A, et al. Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children. JAMA. 2013;309(23):2473-9.

Kahaly GJ, Frommer L, Schuppan D. Celiac disease and endocrine autoimmunity—the genetic link. Autoimmun Rev. 2018;17(12):1169-75.

Hovinga IC, Stam ED, Mearin ML, Mul D. A girl with type 1 diabetes and a yellowish appearance. BMJ Case Rep. 2010;bcr0420102899.

Von Laer Tschudin L, Schwitzgebel VM, Von Scheven-Gete A, Blouin JL, Hofer M, Hauschild M, et al. Diabetes and immune thrombocytopenic purpura : a new association with good response to anti-CD20 therapy. Pediatr Diabetes. 2015;16(2):138-45.

Quintana L, Paniagua JA, Gil-Contreras D, Jimenez-Yuste V, Torres A, Velasco F. Improving type 1 diabetes after treatment of immune thrombocytopenia with rituximab: killing two birds with one stone. Diabetes care. 2010;33(9):e122.

Hennes EM, Zeniya M, Czaja AJ, Parés A, Dalekos GN, Krawitt EL, et al. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology. 2008;48(1):169-76.

Choudhuri K, Gregorio GV, Mieli-Vergani G, Vergani D. Immunological cross-reactivity to multiple autoantigens in patients with liver kidney microsomal type 1 autoimmune hepatitis. Hepatology. 1998;28(5):1177-81.

Erlich H, Valdes AM, Noble J, Carlson JA, Varney M, Concannon P, et al. HLA DR-DQ haplotypes and genotypes and type 1 diabetes risk: analysis of the type 1 diabetes genetics consortium families. Diabetes. 2008;57(4):1084-92.

Al-Hussaini AA, Alzahrani MD, Alenizi AS, Suliman NM, Khan MA, Alharbi SA, et al. Autoimmune hepatitis related autoantibodies in children with type 1 diabetes. Diabetol Metab Syndr. 2014;6(1):38.

Perheentupa J. APS-I/APECED : the clinical disease and therapy. Endocrinol Metab Clin North Am. 2002;31(2):295-320.

Van den Driessche A, Eenkhoorn V, Van Gaal L, De Block C. Type 1 diabetes and autoimmune polyglandular syndrome: a clinical review. Neth J Med. 2009;67(11):376-87.

Fierabracci A. Type 1 Diabetes in Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy Syndrome (APECED): A “Rare” Manifestation in a “Rare” Disease. Int J Mol Sci. 2016;17(7):1106.

Downloads

Published

2026-04-23

How to Cite

Syal, S., Goel, A. K., Jondhale, S., Jagzape, T. B., Gujarathi, A., Jain, A., & Gandhoke , C. S. (2026). Autoimmune conundrum in children with type 1 diabetes mellitus: a case series of uncommon associations. International Journal of Contemporary Pediatrics, 13(5), 757–761. https://doi.org/10.18203/2349-3291.ijcp20261141

Issue

Section

Case Series